{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T08:52:24Z","timestamp":1765356744703,"version":"3.37.3"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2020,7,14]],"date-time":"2020-07-14T00:00:00Z","timestamp":1594684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,7,14]],"date-time":"2020-07-14T00:00:00Z","timestamp":1594684800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100000028","name":"Institute of Circulatory and Respiratory Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000028","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["OBES SURG"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1007\/s11695-020-04450-2","type":"journal-article","created":{"date-parts":[[2020,7,14]],"date-time":"2020-07-14T10:04:08Z","timestamp":1594721048000},"page":"3714-3720","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Acute and Chronic Impact of Biliopancreatic Diversion with Duodenal Switch Surgery on Plasma Lipoprotein(a) Levels in Patients with Severe Obesity"],"prefix":"10.1007","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0285-3512","authenticated-orcid":false,"given":"Audrey-Anne","family":"Despr\u00e9s","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-Eve","family":"Pich\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Audrey","family":"Auclair","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurent","family":"Biertho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"Marceau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fr\u00e9d\u00e9ric-Simon","family":"Hould","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"Biron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"St\u00e9fane","family":"Lebel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Odette","family":"Lescelleur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7ois","family":"Julien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9","family":"Tchernof","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Mathieu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Poirier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benoit J.","family":"Arsenault","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,7,14]]},"reference":[{"issue":"26","key":"4450_CR1","doi-asserted-by":"publisher","first-page":"2518","DOI":"10.1056\/NEJMoa0902604","volume":"361","author":"R Clarke","year":"2009","unstructured":"Clarke R, Peden JF, Hopewell JC, et al. Genetic variants associated with Lp(a) lipoprotein level and coronary disease. N Engl J Med. 2009;361(26):2518\u201328.","journal-title":"N Engl J Med"},{"issue":"25","key":"4450_CR2","doi-asserted-by":"publisher","first-page":"2761","DOI":"10.1016\/j.jacc.2016.10.033","volume":"68","author":"CA Emdin","year":"2016","unstructured":"Emdin CA, Khera AV, Natarajan P, et al. Phenotypic characterization of genetically lowered human lipoprotein(a) levels. J Am Coll Cardiol. 2016;68(25):2761\u201372.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"4450_CR3","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1172\/JCI115855","volume":"90","author":"E Boerwinkle","year":"1992","unstructured":"Boerwinkle E, Leffert CC, Lin J, et al. Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations. J Clin Invest. 1992;90(1):52\u201360.","journal-title":"J Clin Invest"},{"issue":"23","key":"4450_CR4","doi-asserted-by":"publisher","first-page":"2844","DOI":"10.1093\/eurheartj\/ehq386","volume":"31","author":"BG Nordestgaard","year":"2010","unstructured":"Nordestgaard BG, Chapman MJ, Ray K, et al. Lipoprotein(a) as a cardiovascular risk factor: current status. Eur Heart J. 2010;31(23):2844\u201353.","journal-title":"Eur Heart J"},{"issue":"6","key":"4450_CR5","first-page":"487","volume":"14","author":"AC Sonnichsen","year":"1990","unstructured":"Sonnichsen AC, Richter WO, Schwandt P. Reduction of lipoprotein (a) by weight loss. Int J Obes. 1990;14(6):487\u201394.","journal-title":"Int J Obes"},{"issue":"3","key":"4450_CR6","first-page":"153","volume":"11","author":"DN Kiortsis","year":"2001","unstructured":"Kiortsis DN, Tzotzas T, Giral P, et al. Changes in lipoprotein(a) levels and hormonal correlations during a weight reduction program. Nutr Metab Cardiovasc Dis. 2001;11(3):153\u20137.","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"6","key":"4450_CR7","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1007\/s00125-017-4246-y","volume":"60","author":"KA Berk","year":"2017","unstructured":"Berk KA, Yahya R, Verhoeven AJM, et al. Effect of diet-induced weight loss on lipoprotein(a) levels in obese individuals with and without type 2 diabetes. Diabetologia. 2017;60(6):989\u201397.","journal-title":"Diabetologia."},{"issue":"2","key":"4450_CR8","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.cjca.2014.12.014","volume":"31","author":"ME Piche","year":"2015","unstructured":"Piche ME, Auclair A, Harvey J, et al. How to choose and use bariatric surgery in 2015. Can J Cardiol. 2015;31(2):153\u201366.","journal-title":"Can J Cardiol"},{"issue":"6","key":"4450_CR9","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1016\/j.jacl.2016.08.014","volume":"10","author":"M Boyer","year":"2016","unstructured":"Boyer M, L\u00e9vesque V, Poirier P, et al. Impact of a 1-year lifestyle modification program on plasma lipoprotein and PCSK9 concentrations in patients with coronary artery disease. J Clin Lipidol. 2016;10(6):1353\u201361.","journal-title":"J Clin Lipidol"},{"issue":"2","key":"4450_CR10","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1381\/096089297765556006","volume":"7","author":"L Boman","year":"1997","unstructured":"Boman L, Ericson M. Lipoprotein a levels after intestinal bypass operation for morbid obesity. Obes Surg. 1997;7(2):125\u20137.","journal-title":"Obes Surg"},{"issue":"1","key":"4450_CR11","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.soard.2006.10.003","volume":"3","author":"DB Williams","year":"2007","unstructured":"Williams DB, Hagedorn JC, Lawson EH, et al. Gastric bypass reduces biochemical cardiac risk factors. Surg Obes Relat Dis. 2007;3(1):8\u201313.","journal-title":"Surg Obes Relat Dis"},{"key":"4450_CR12","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.ahj.2017.10.020","volume":"197","author":"BX Lin","year":"2018","unstructured":"Lin BX, Weiss MC, Parikh M, et al. Changes in lipoprotein(a) following bariatric surgery. Am Heart J. 2018;197:175\u20136.","journal-title":"Am Heart J"},{"issue":"1","key":"4450_CR13","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.metabol.2013.09.004","volume":"63","author":"M-\u00c8 Pich\u00e9","year":"2014","unstructured":"Pich\u00e9 M-\u00c8, Martin J, Cianflone K, et al. Changes in predicted cardiovascular disease risk after biliopancreatic diversion surgery in severely obese patients. Metabolism. 2014;63(1):79\u201386.","journal-title":"Metabolism."},{"issue":"6","key":"4450_CR14","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","volume":"18","author":"WT Friedewald","year":"1972","unstructured":"Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18(6):499\u2013502.","journal-title":"Clin Chem"},{"issue":"9","key":"4450_CR15","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1055\/s-0032-1323738","volume":"120","author":"VT To","year":"2012","unstructured":"To VT, Huttl TP, Lang R, et al. Changes in body weight, glucose homeostasis, lipid profiles, and metabolic syndrome after restrictive bariatric surgery. Exp Clin Endocrinol Diabetes. 2012;120(9):547\u201352.","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"5","key":"4450_CR16","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1007\/s11695-010-0088-0","volume":"20","author":"GA Woodard","year":"2010","unstructured":"Woodard GA, Peraza J, Bravo S, et al. One year improvements in cardiovascular risk factors: a comparative trial of laparoscopic Roux-en-Y gastric bypass vs. adjustable gastric banding. Obes Surg. 2010;20(5):578\u201382.","journal-title":"Obes Surg"},{"issue":"1","key":"4450_CR17","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/j.1365-2796.2012.02592.x","volume":"273","author":"F Kronenberg","year":"2013","unstructured":"Kronenberg F, Utermann G. Lipoprotein(a): resurrected by genetics. J Intern Med. 2013;273(1):6\u201330.","journal-title":"J Intern Med"},{"issue":"3","key":"4450_CR18","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1213\/ANE.0000000000000263","volume":"119","author":"C Santonocito","year":"2014","unstructured":"Santonocito C, De Loecker I, Donadello K, et al. C-reactive protein kinetics after major surgery. Anesth Analg. 2014;119(3):624\u20139.","journal-title":"Anesth Analg"},{"issue":"7","key":"4450_CR19","doi-asserted-by":"publisher","first-page":"2690","DOI":"10.1210\/jc.2015-1096","volume":"100","author":"A Langsted","year":"2015","unstructured":"Langsted A, Varbo A, Kamstrup PR, et al. Elevated lipoprotein(a) does not cause low-grade inflammation despite causal association with aortic valve stenosis and myocardial infarction: a study of 100,578 individuals from the general population. J Clin Endocrinol Metab. 2015;100(7):2690\u20139.","journal-title":"J Clin Endocrinol Metab"},{"key":"4450_CR20","doi-asserted-by":"crossref","first-page":"480784","DOI":"10.1155\/2012\/480784","volume":"2012","author":"I Missala","year":"2012","unstructured":"Missala I, Kassner U, Steinhagen-Thiessen E. A systematic literature review of the association of lipoprotein(a) and autoimmune diseases and atherosclerosis. Int J Rheumatol. 2012;2012:480784.","journal-title":"Int J Rheumatol"},{"issue":"1","key":"4450_CR21","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.atherosclerosis.2014.01.049","volume":"234","author":"A Langsted","year":"2014","unstructured":"Langsted A, Kamstrup PR, Nordestgaard BG. Lipoprotein(a): fasting and nonfasting levels, inflammation, and cardiovascular risk. Atherosclerosis. 2014;234(1):95\u2013101.","journal-title":"Atherosclerosis."},{"issue":"5","key":"4450_CR22","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1194\/jlr.P052209","volume":"56","author":"N Muller","year":"2015","unstructured":"Muller N, Schulte DM, Turk K, et al. IL-6 blockade by monoclonal antibodies inhibits apolipoprotein (a) expression and lipoprotein (a) synthesis in humans. J Lipid Res. 2015;56(5):1034\u201342.","journal-title":"J Lipid Res"},{"issue":"6","key":"4450_CR23","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1007\/s11695-012-0643-y","volume":"22","author":"F Illan-Gomez","year":"2012","unstructured":"Illan-Gomez F, Gonzalvez-Ortega M, Orea-Soler I, et al. Obesity and inflammation: change in adiponectin, C-reactive protein, tumour necrosis factor-alpha and interleukin-6 after bariatric surgery. Obes Surg. 2012;22(6):950\u20135.","journal-title":"Obes Surg"},{"issue":"12","key":"4450_CR24","doi-asserted-by":"publisher","first-page":"e14328","DOI":"10.1371\/journal.pone.0014328","volume":"5","author":"O Schultz","year":"2010","unstructured":"Schultz O, Oberhauser F, Saech J, et al. Effects of inhibition of interleukin-6 signalling on insulin sensitivity and lipoprotein (a) levels in human subjects with rheumatoid diseases. PLoS One. 2010;5(12):e14328.","journal-title":"PLoS One"},{"issue":"6","key":"4450_CR25","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1093\/ajcn\/85.6.1527","volume":"85","author":"MJ Shin","year":"2007","unstructured":"Shin MJ, Blanche PJ, Rawlings RS, et al. Increased plasma concentrations of lipoprotein(a) during a low-fat, high-carbohydrate diet are associated with increased plasma concentrations of apolipoprotein C-III bound to apolipoprotein B-containing lipoproteins. Am J Clin Nutr. 2007;85(6):1527\u201332.","journal-title":"Am J Clin Nutr"},{"issue":"3","key":"4450_CR26","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1161\/01.ATV.0000118012.64932.f4","volume":"24","author":"ML Silaste","year":"2004","unstructured":"Silaste ML, Rantala M, Alfthan G, et al. Changes in dietary fat intake alter plasma levels of oxidized low-density lipoprotein and lipoprotein(a). Arterioscler Thromb Vasc Biol. 2004;24(3):498\u2013503.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"11","key":"4450_CR27","doi-asserted-by":"publisher","first-page":"3324","DOI":"10.1194\/jlr.M005769","volume":"51","author":"N Faghihnia","year":"2010","unstructured":"Faghihnia N, Tsimikas S, Miller ER, et al. Changes in lipoprotein(a), oxidized phospholipids, and LDL subclasses with a low-fat high-carbohydrate diet. J Lipid Res. 2010;51(11):3324\u201330.","journal-title":"J Lipid Res"},{"issue":"3","key":"4450_CR28","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1161\/01.ATV.18.3.441","volume":"18","author":"HN Ginsberg","year":"1998","unstructured":"Ginsberg HN, Kris-Etherton P, Dennis B, et al. Effects of reducing dietary saturated fatty acids on plasma lipids and lipoproteins in healthy subjects: the DELTA Study, protocol 1. Arterioscler Thromb Vasc Biol. 1998;18(3):441\u20139.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"12","key":"4450_CR29","doi-asserted-by":"publisher","first-page":"e114859","DOI":"10.1371\/journal.pone.0114859","volume":"9","author":"B Haring","year":"2014","unstructured":"Haring B, von Ballmoos MC, Appel LJ, et al. Healthy dietary interventions and lipoprotein (a) plasma levels: results from the Omni Heart Trial. PLoS One. 2014;9(12):e114859.","journal-title":"PLoS One"},{"issue":"6","key":"4450_CR30","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1097\/SLA.0000000000001552","volume":"264","author":"C Jahansouz","year":"2016","unstructured":"Jahansouz C, Xu H, Hertzel AV, et al. Bile acids increase independently from hypocaloric restriction after bariatric surgery. Ann Surg. 2016;264(6):1022\u20138.","journal-title":"Ann Surg"},{"issue":"9","key":"4450_CR31","doi-asserted-by":"publisher","first-page":"3724","DOI":"10.1172\/JCI45277","volume":"121","author":"I Chennamsetty","year":"2011","unstructured":"Chennamsetty I, Claudel T, Kostner KM, et al. Farnesoid X receptor represses hepatic human APOA gene expression. J Clin Invest. 2011;121(9):3724\u201334.","journal-title":"J Clin Invest"},{"issue":"5","key":"4450_CR32","first-page":"218","volume":"26","author":"P Calmarza","year":"2014","unstructured":"Calmarza P, Bajador E, Lapresta C, et al. Effect of biliary obstruction on lipoprotein(a) concentration. Clin Investig Arterioscler. 2014;26(5):218\u201323.","journal-title":"Clin Investig Arterioscler"},{"issue":"4","key":"4450_CR33","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1161\/CIRCULATIONAHA.116.025253","volume":"135","author":"G Reyes-Soffer","year":"2017","unstructured":"Reyes-Soffer G, Pavlyha M, Ngai C, et al. Effects of PCSK9 inhibition with alirocumab on lipoprotein metabolism in healthy humans. Circulation. 2017;135(4):352\u201362.","journal-title":"Circulation."},{"issue":"1","key":"4450_CR34","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.jacl.2017.10.001","volume":"12","author":"BJ Arsenault","year":"2018","unstructured":"Arsenault BJ, Petrides F, Tabet F, et al. Effect of atorvastatin, cholesterol ester transfer protein inhibition, and diabetes mellitus on circulating proprotein subtilisin kexin type 9 and lipoprotein(a) levels in patients at high cardiovascular risk. J Clin Lipidol. 2018;12(1):130\u20136.","journal-title":"J Clin Lipidol"}],"container-title":["Obesity Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11695-020-04450-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11695-020-04450-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11695-020-04450-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,13]],"date-time":"2021-07-13T23:48:06Z","timestamp":1626220086000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11695-020-04450-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,14]]},"references-count":34,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["4450"],"URL":"https:\/\/doi.org\/10.1007\/s11695-020-04450-2","relation":{},"ISSN":["0960-8923","1708-0428"],"issn-type":[{"type":"print","value":"0960-8923"},{"type":"electronic","value":"1708-0428"}],"subject":[],"published":{"date-parts":[[2020,7,14]]},"assertion":[{"value":"3 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The ethics committee of the IUCPQ approved the experimental protocol and all patients gave their written informed consent before being included in the study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Andr\u00e9 Tchernof and Laurent Biertho report grants from Johnson & Johnson Medical and grants from Medtronic, during the conduct of the study. All other authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}